基于M-Z干涉原理的定位式光纤振动传感器

文章基于M-Z（Mach-Zehnder）干涉原理,提出了一种新型光纤振动传感器方案,该传感器能判断振动事件发生的位置。仿真分析研究了该定位式传感器的信号处理技术,通过增大信号的带宽、延长信号的持续时间、增大信噪比和改善定位算法,实现了较好的定位性能,验证了该定位式光纤振动传感器方案的可行性

一种高分辨率分布式光纤温度传感系统的研究

文章介绍了一种高分辨率分布式光纤温度传感系统,该系统利用光波在光纤中传输时的拉曼散射效应,探测其背向拉曼散射光强度,并根据反射光强与温度的关系来进行传感光纤沿途温度的探测。文章详细探讨了系统的工作原理,搭建了实验平台,并进行了温度传感实验。实验证明,系统的温度精度达到0.1℃,空间定位分辨率为1 m

新型超远程分布式光纤拉曼温度传感器

基于光中继传感技术提出一种超远程分布式光纤拉曼温度传感器方案,采用在分布式光纤传感器的多段传感光缆之间嵌入多级光中继放大传感装置的方式,利用中继放大传感装置的增益克服光纤损耗,增强了光纤中自发拉曼散射光的强度,传感光缆分段分时进行测量。当在多段传感光缆之间引入N个远程光中继放大传感装置进行级联时,可实现分布式光纤传感器的N×L（L为每段传感光纤的长度）超远程监测。文章最后给出了实际测量结果,结果表明,该系统能在60 km的传感探测长度上获取具有较高信噪比的传感信号

名古屋大学アイソトープ総合センターに設置されたγ線自動測定・解析システムによる地質試料の中性子放射化分析手順と分析精度

A new gamma-ray counting and data processing system for non-destructive neutron activation analysis has been set up in Radioisotope Center in Nagoya University. The system carry out gamma-ray counting, sample change and data processing automatically, and is able to keep us away from parts of complicated operations in INAA. In this study, we have arranged simple analytical procedure that makes practical works easier than previous. The concrete flow is described from the preparation of powder rock samples to gamma-ray counting and data processing by the new INAA system. Then it is run over that the analyses used two Geological Survey of Japan rock reference samples JB-1a and JG-1a in order to evaluate how the new analytical procedure give any speediness and accuracy for analyses of geological materials. Two United States Geological Survey reference samples BCR-1 and G-2 used as the standard respectively. Twenty two elements for JB-1a and 25 elements for JG-1a were analyzed, the uncertainty are <5% for Na, Sc, Fe, Co, La, Ce, Sm, Eu, Yb, Lu, Hf, Ta and Th, and of <10% for Cr, Zn, Cs, Ba, Nd, Tb and U. This system will enable us to analyze more than 1500 geologic samples per year.国立情報学研究所で電子化したコンテンツを使用している

Clinical evaluation of flutamide, a pure antiandrogen, in prostatic cancer phase II dose-finding study

1)内分泌療法未治療の前立腺癌症例に対し, 375mg/日の用量で単独療法として使用しえる。この際, testosterone産生阻害療法に比し, 「生活の質」が保たれる。2)内分泌療法再燃例に対しても, ある程度その効果が期待できる。3)フルタミドと他の精巣性testosterone阻害剤との併用で, その併用効果が期待できる。4)また, LH-RHアナログの投与によるflare-up現象をフルタミドを併用することにより予防することが可能であるThe phase II study of flutamide, a pure anti-androgen, was performed to estimate the clinical doses on 165 hormone untreated or treated patients with prostatic cancer. The hormone-untreated patients were given orally flutamide of 90, 375, 750 or 1, 125 mg/day in three divided doses daily for 12 weeks. Responses were not observed at the 90 mg/day dose except for improvement of clinical symptoms. However, an objective response rate of 48.8-46.7% was obtained at 375-1, 125 mg/day doses. In hormone-treated patients including cases refractory to the previous hormonal treatment, the objective response rates were 13.3 and 8.3% in 375 and 750 mg/day flutamide groups, respectively. Side effects such as gynecomastia, nausea, vomiting, diarrhea, and abnormal laboratory findings such as the elevation of hepatic transaminases were observed. The incidence increased dose-dependently. Determinations of serum hormone levels revealed an increase in testosterone levels by the use of flutamide. In conclusion 375 mg/day of flutamide is the optimal dose in monotherapy for hormone-untreated patients with prostatic cancer, where the quality of life can be maintained compared with therapies involving testosterone suppression. This dose is also expected to show some efficacy in cases refractory to hormone treatment